Article Text

Download PDFPDF

Clinical and research medicine: Interventional cardiology
e0497 Clinical evaluation on the safety and therapeutic efficacy of Excel drug-eluting stent
  1. Jun Tang,
  2. Xiaoqian Li,
  3. Hegui Wang,
  4. Xuejun Hu,
  5. Wenjun Gao,
  6. Jun Wang,
  7. Dabin Pan,
  8. Yongsheng Ke
  1. Department of Cardiovascular Diseases, Yijishan Hospital, Wannan Medical College, Wuhu


Objective To investigate the clinical safety and mid-and short-term efficacy of rapamycin eluting stent (Excel) in patients with coronary artery disease.

Methods Between Jul. 2006 and Jun. 2009, 240 patients of coronary heart disease received percutaneous coronary intervention (PCI) with Excel stent and were followed up from 6 to 24 months for observing the incidence of angina pectoris, myocardial infarction, sudden death and revascularization.

Results 327 pieces of Excel stent were implanted in 272 target lesions (269 with de novo and 3 of restenosis), but 2 cases failed due to seriously deformed middle anterior descending artery from calcification in 1 and the angle of middle circumflex branch larger than 90 degrees in another to prevent the passage. 325 pieces of stent were successfully implanted, and the postoperative follow-up in the 8th to 18th month showed that angina pectoris occurred in 5, restenosis in 2 and normal in 3 by coronary arteriongraphy, suspected thrombosis in 1 at the 5th month after the operation regarding ventricular fibrillation, haemorrhage of upper digestive tract in 4 at the 6th month of the intervention, in which 1 underwent inpatient therapy with blood transfusion. The postoperative major coronary adverse event accounted for 4.58% between 6 and 24 months.

Conclusion Excel drug-eluting stent may be excellent in treatment of coronary artery diseases with regard to its safety and mid-and short-term effect.

  • Rapamycin
  • stent
  • coronary artery disease
  • interventional therapy

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.